Morgan Sheng
Corporate Officer/Principal at Massachusetts Institute of Technology
Morgan Sheng active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Career history of Morgan Sheng
Former positions of Morgan Sheng
| Companies | Position | Start | End |
|---|---|---|---|
| PREVAIL THERAPEUTICS INC. | Director/Board Member | 2019-11-14 | 2021-01-21 |
| Independent Dir/Board Member | 2019-11-14 | 2021-01-21 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2008-09-14 | - |
Training of Morgan Sheng
| University of Oxford | Undergraduate Degree |
| University of London | Doctorate Degree |
| Harvard University | Doctorate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 3 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Morgan Sheng
- Experience
